(4-(5-chloropyridin-2-yl)piperazin-1-yl)((1S,2S,4R)-4-(1-(4-methoxyphenyl)cyclopropylamino)-2-(thiophen-3-yl)cyclohexyl)methanone

ID: ALA1940525

PubChem CID: 57398360

Max Phase: Preclinical

Molecular Formula: C30H35ClN4O2S

Molecular Weight: 551.16

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(C2(N[C@@H]3CC[C@H](C(=O)N4CCN(c5ccc(Cl)cn5)CC4)[C@@H](c4ccsc4)C3)CC2)cc1

Standard InChI:  InChI=1S/C30H35ClN4O2S/c1-37-25-6-2-22(3-7-25)30(11-12-30)33-24-5-8-26(27(18-24)21-10-17-38-20-21)29(36)35-15-13-34(14-16-35)28-9-4-23(31)19-32-28/h2-4,6-7,9-10,17,19-20,24,26-27,33H,5,8,11-16,18H2,1H3/t24-,26+,27-/m1/s1

Standard InChI Key:  CFKXYDIIHXGQEA-FXVJXKIMSA-N

Molfile:  

     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   16.2167  -13.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2167  -14.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9287  -14.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6407  -14.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6407  -13.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9287  -13.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3564  -13.1313    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0696  -13.5459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7853  -13.1354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4989  -13.5557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2141  -13.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2169  -12.3201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4987  -11.9057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7864  -12.3178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9321  -11.9088    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.6459  -12.3224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9283  -15.6003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2609  -16.0852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5158  -16.8698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3409  -16.8698    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   17.5957  -16.0852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5028  -14.7802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7877  -14.3687    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5040  -15.6052    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.7842  -13.5405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0732  -13.1291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3569  -13.5391    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3561  -14.3651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0717  -14.7810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6425  -13.1208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6457  -12.2947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9331  -11.8806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2167  -12.2915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2243  -13.1208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9306  -13.5311    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.5009  -11.8813    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   18.6500  -14.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4750  -14.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  9 10  2  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 17  2  0
  3 17  1  6
  3  4  1  0
  2 22  1  1
 10 11  1  0
 22 23  1  0
  4  5  1  0
 22 24  2  0
 23 25  1  0
 11 12  2  0
  5  6  1  0
 12 13  1  0
 13 14  2  0
 23 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 14  9  1  0
  5  7  1  1
 30 31  2  0
 12 15  1  0
 31 32  1  0
  1  2  1  0
 32 33  2  0
 15 16  1  0
 33 34  1  0
 17 18  1  0
 34 35  2  0
 35 30  1  0
 27 30  1  0
  7  8  1  0
 33 36  1  0
  1  6  1  0
  8 37  1  0
  8  9  1  0
  8 38  1  0
 37 38  1  0
M  END

Associated Targets(non-human)

Npbwr1 Neuropeptides B/W receptor type 1 (82 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 551.16Molecular Weight (Monoisotopic): 550.2169AlogP: 5.69#Rotatable Bonds: 7
Polar Surface Area: 57.70Molecular Species: BASEHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.19CX LogP: 5.35CX LogD: 3.56
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.41Np Likeness Score: -1.50

References

1. Anthony Romero F, Hastings NB, Moningka R, Guo Z, Wang M, Di Salvo J, Lei Y, Trusca D, Deng Q, Tong V, Terebetski JL, Ball RG, Ujjainwalla F..  (2012)  The discovery of potent antagonists of NPBWR1 (GPR7).,  22  (2): [PMID:22197390] [10.1016/j.bmcl.2011.11.126]

Source